Document Type : Case Report
Authors
1 Infectious and Tropical Research Center, Kerman University of Medical Sciences, Kerman, Iran & Clinical Research Development Unit, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
2 Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran & Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran
3 Department of Pediatrics, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
4 Department of Pediatrics, School of Medicine, Afzalipour Hospital, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background: While the exact prevalence of bacterial co-infection and superinfection in children with coronavirus disease 2019 (COVID-19) remains unclear, numerous scattered reports of it are on the rise.
Case Presentation: Our case was a 14-month-old infant with fever, truncal erythema, and scalded skin in flexor folds and also in perianal and perioral regions. A positive Nikolsky’s sign was observed. The oropharyngeal mucosa was intact. The patient was diagnosed with staphylococcal scalded skin syndrome (SSSS) according to clinical features and a skin culture report. Due to the general impact of COVID-19 these days, the patient was evaluated for coronavirus via a polymerase chain reaction (PCR) test, and the result was positive. The patient successfully responded to the treatment which included hydration, wet compress, topical emollient, topical mupirocin for periorificial regions, and intravenous clindamycin. He was discharged after nine days without any complications.
Conclusion: This case highlights a clear bacterial infection superimposed on COVID-19. Nevertheless, inconspicuous cases of co-infections remain obscure and require a more diagnostic suspicion.
Keywords
is less frequent and severe in children: a narrative review.
World J Pediatr. 2021;17(1):10-20. doi: 10.1007/s12519-
020-00392-y.
2. Sinaei R, Hosseininasab A, Jafari M, Eslami S, Parvaresh
S. The Multisystem Inflammatory Syndrome of Childhood
(MIS-C). Indian J Pediatr. 2021;88(5):484. doi: 10.1007/
s12098-020-03617-0.
3. Sinaei R, Pezeshki S, Parvaresh S, Sinaei R, Shiari R, Hassas
Yeganeh M, et al. Post SARS-CoV-2 infection reactive arthritis:
a brief report of two pediatric cases. Pediatr Rheumatol
Online J. 2021;19(1):89. doi: 10.1186/s12969-021-00555-9.
4. Clancy CJ, Schwartz IS, Kula B, Nguyen MH. Bacterial
superinfections among persons with coronavirus disease
2019: a comprehensive review of data from postmortem
studies. Open Forum Infect Dis. 2021;8(3):ofab065. doi:
10.1093/ofid/ofab065.
5. Musuuza JS, Watson L, Parmasad V, Putman-Buehler N,
Christensen L, Safdar N. Prevalence and outcomes of coinfection
and superinfection with SARS-CoV-2 and other
pathogens: a systematic review and meta-analysis. PLoS One.
2021;16(5):e0251170. doi: 10.1371/journal.pone.0251170.
6. Venturini E, Montagnani C, Garazzino S, Donà D, Pierantoni
L, Lo Vecchio A, et al. Treatment of children with COVID-19:
position paper of the Italian Society of Pediatric Infectious
Disease. Ital J Pediatr. 2020;46(1):139. doi: 10.1186/s13052-
020-00900-w.
7. Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde
P, Garcia-Pouton N, Chumbita M, et al. Incidence of coinfections
and superinfections in hospitalized patients with
COVID-19: a retrospective cohort study. Clin Microbiol
Infect. 2021;27(1):83-8. doi: 10.1016/j.cmi.2020.07.041.
8. Cawcutt K, Kalil AC. Pneumonia with bacterial and viral
coinfection. Curr Opin Crit Care. 2017;23(5):385-90. doi:
10.1097/mcc.0000000000000435.
9. Hendaus MA, Jomha FA. COVID-19 induced superimposed
bacterial infection. J Biomol Struct Dyn. 2021;39(11):4185-
91. doi: 10.1080/07391102.2020.1772110.
10. Nag VL, Kaur N. Superinfections in COVID-19 patients: role
of antimicrobials. Dubai Med J. 2021;4(2):117-26.
11. Bhat N, Wright JG, Broder KR, Murray EL, Greenberg
ME, Glover MJ, et al. Influenza-associated deaths among
children in the United States, 2003-2004. N Engl J Med.
2005;353(24):2559-67. doi: 10.1056/NEJMoa051721.
12. Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson
BT, Yoon G, et al. Critically ill children during the 2009-
2010 influenza pandemic in the United States. Pediatrics.
2011;128(6):e1450-8. doi: 10.1542/peds.2011-0774.
13. Spoto S, Valeriani E, Riva E, De Cesaris M, Tonini G,
Vincenzi B, et al. A Staphylococcus aureus coinfection on a
COVID-19 pneumonia in a breast cancer patient. Int J Gen
Med. 2020;13:729-33. doi: 10.2147/ijgm.s261760.
14. Wang J, Tang Y, Ma Y, Zhou Q, Li W, Baskota M, et al.
Efficacy and safety of antibiotic agents in children with
COVID-19: a rapid review. Ann Transl Med. 2020;8(10):619.
doi: 10.21037/atm-20-3300.
15. Bitar C, Chan MP, Harms PW, Fullen DR, Gudjonsson JE,
Eshaq M, et al. Cutaneous manifestations of hospitalized
coronavirus disease 2019 patients: a report of six cases with
clinicopathologic features and viral RNA in situ hybridization.
J Eur Acad Dermatol Venereol. 2020;34(11):e656-e9. doi:
10.1111/jdv.16741.
16. Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M.
Cutaneous and histopathological features of coronavirus
disease 2019 in pediatrics: a review article. Dermatol Ther.
2021;34(1):e14554. doi: 10.1111/dth.14554.
)